Lab-Care Diagnostics (India) Pvt. Ltd. is one of the leading manufacturers in the medical device industry, in the field of
In Vitro Diagnostics (IVD).
The Lab-Care Diagnostics Ecosystem
Lab-Care Diagnostics Pvt Ltd., under the visionary leadership team, has built the competency muscle, quality culture and the robust manufacturing platform to meet with the future demands of the market.
We have developed applications for almost all of the Immuno In-Vitro Diagnostics (IVD) Market segments:
Lab-Care products are manufactured at its state-of-the-art facility in Sarigam, covering an area of 18,000 sq. ft. The present line of products includes Clinical Chemistry reagents, Urine reagent strips, Serology products and rapid tests for Infectious Diseases.
These products are being supplied in the company’s own brand namely ACCUCARE®, as well as in OEM bulk, pre‐dispensed vials (labelled and unlabelled), in white boxes or in specific designed boxes for its overseas customers.
All the key operations are headed by Biotechnologists who are ably supported with trained team members.
During the present pandemic scenario, Lab-Care leveraged their strength to start in house manufacturing of COVID-19 antigen Rapid kits, COVID-19 antibody Rapid kits, COVID-19 IgG & Neutralizing Ab Elisa kits, Viral Transport Medium (VTM), D-Dimer kits, Ferritin & CRP Turbilatex, etc. and in record time got ICMR approvals. They shouldered the responsibility by creating a robust line of defense for the nation, to control the spread of COVID-19 effectively and swiftly.
We are the first company who developed COVID-19 Antigen Rapid Test Kits in India.
The company is adhering to the ISO 13485:2016 standard and Fifth Schedule in Medical Device Rules, 2017 (MDR-2017), Central Drugs Standard Control Organisation (CDSCO), Govt. of India, of Quality Management system. As per the regulatory requirement some of the products are CE certified. All products manufactured by the company follow GMP guidelines. The company has been licensed for manufacturing its products by the Indian Food & Drug Association (FDA) and Central Drugs Standard Control Organisation (CDSCO). The facility is equipped with the latest instrumentations and a robust process controlled and directed as per the Quality Management systems.
“We believe in specialization and have successfully created a culture of quality consciousness as foundation of our work.”
“The success of Lab-Care Diagnostics (India) Pvt. Ltd. is purely TEAMWORK.”
The IVD industry of the world especially India has observed phenomenal changes in logistics capabilities, testing capacities, reporting, practically all activities.
India alone has registered 400% growth in the number of new labs which started molecular testing during the pandemic. By mid-March 2021, India has crossed 2400 molecular laboratories performing Covid-19 PCR testing.
This is a huge step toward making India Atmanirbhar for complex disease testing where molecular techniques are proven to be the gold standard. Lab-Care Diagnostic Pvt Ltd has developed product lines and solutions that are a unique competitive advantage in the growing segment of the IVD market. Our research team is continuously working on development of unique products.
At the heart of our Work is creating Opportunities to grow for all stakeholders and interested parties.
Lab-Care Diagnostics is constantly looking at synergies to realize common goals and aspirations.
We look forward to connecting with organizations/institutions/private industries to form a strategic partnership in areas of technology transfer, joint venture, research collaboration, OEM supplies and other opportunities.
-Peter F. Drucker